Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01427946
Brief Title: Phase 1b/2 Study of Retaspimycin HCl (IPI-504) in Combination With Everolimus in KRAS Mutant Non-small Cell Lung Cancer

First Submitted : August 31, 2011
First Submitted that Met QC Criteria : September 1, 2011
First Posted : September 2, 2011 (Estimate)

Last Update Submitted that Met QC Criteria : November 12, 2014
Last Update Posted : November 13, 2014 (Estimate)